Share

March 10, 2015; 84 (10) Editorial

Parkinson disease GWAS

The question of lumping or splitting is back again

Javier Simón-Sánchez, Thomas Gasser
First published February 6, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001345
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
346

Share

Article Information

vol. 84 no. 10 966-967
DOI: 
https://doi.org/10.1212/WNL.0000000000001345
PubMed: 
25663226
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 6, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Javier Simón-Sánchez, PhD and
    2. Thomas Gasser, MD
  1. Javier Simón-Sánchez, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Thomas Gasser, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Genetics and Epigenetics of Neurodegeneration (J.S.-S.) and Department of Neurodegenerative Diseases (T.G.), Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (J.S.-S., T.G.), Tübingen, Germany.
  1. Correspondence to Prof. Dr. Gasser: thomas.gasser{at}med.uni-tuebingen.de
View Full Text

Article usage

Article usage: February 2015 to May 2022

AbstractFullPdfSource
Feb 2015163045Highwire
Mar 20155946375Highwire
Apr 2015661115Highwire
May 2015871115Highwire
Jun 201565106Highwire
Jul 20156734Highwire
Aug 20154910Highwire
Sep 20153531Highwire
Oct 20151263Highwire
Nov 20151386Highwire
Dec 20153455Highwire
Jan 20161932Highwire
Feb 20161022Highwire
Mar 20161053Highwire
Apr 20162412Highwire
May 20162912Highwire
Jun 20161142Highwire
Jul 2016912Highwire
Aug 20161901Highwire
Sep 20161800Highwire
Oct 20162845Highwire
Nov 20162702Highwire
Dec 20161811Highwire
Jan 20171901Highwire
Feb 20173701Highwire
Mar 20174323Highwire
Apr 20173602Highwire
May 20174602Highwire
Jun 20173605Highwire
Jul 20174409Highwire
Aug 20172802Highwire
Sep 20172203Highwire
Oct 20173123Highwire
Nov 20172204Highwire
Dec 20172503Highwire
Jan 20182814Highwire
Feb 20182303Highwire
Mar 20184007Highwire
Apr 20183616Highwire
May 20183514Highwire
Jun 20184506Highwire
Jul 20182504Highwire
Aug 20183535Highwire
Sep 20181734Highwire
Oct 201832012Highwire
Nov 20181404Highwire
Dec 20182217Highwire
Jan 2019713Highwire
Feb 20191615Highwire
Mar 20192807Highwire
Apr 20192515Highwire
May 20191418Highwire
Jun 20191222Highwire
Jul 2019800Highwire
Aug 2019810Highwire
Sep 20191702Highwire
Oct 20191902Highwire
Nov 20191000Highwire
Dec 20191711Highwire
Jan 2020300Highwire
Feb 2020700Highwire
Mar 20202700Highwire
Apr 20201011Highwire
May 2020201Highwire
Jun 2020611Highwire
Jul 2020400Highwire
Aug 2020212Highwire
Sep 2020310Highwire
Oct 2020701Highwire
Nov 2020710Highwire
Dec 2020400Highwire
Jan 20211000Highwire
Feb 20211400Highwire
Mar 20211111Highwire
Apr 20211000Highwire
May 20211100Highwire
Jun 2021300Highwire
Jul 20212100Highwire
Aug 20211000Highwire
Sep 2021111Highwire
Oct 2021800Highwire
Nov 20211400Highwire
Dec 2021600Highwire
Jan 2022700Highwire
Feb 20222400Highwire
Mar 20222100Highwire
Apr 20221800Highwire
May 2022700Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me